Cordlife Secures One-Year Renewal of Service License; Shares Surge 19%

MT Newswires
01/14

Cordlife (SGX:P8A) secured a one-year renewal of its cord blood banking service license, according to a Wednesday filing with the Singapore Exchange.

The company also received a two-year renewal for its human tissue banking service license from Jan. 14 to Jan. 13, 2028.

Under the conditions of the renewal of the two licenses, the company cannot collect, test, process and store CBUs from infant donors and is also required to replace its clinical governance officer and hire a suitable replacement.

Meanwhile, the company is also required to retrain its laboratory personnel.

Shares of the company surged nearly 19% in Wednesday trading.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10